Dow Jones Newswires: Valneva shares keep rising after Pfizer deal

This article was originally published on MarketWatch

Valneva SE’s shares continue to trade higher on Tuesday following news that U.S. peer Pfizer Inc. has agreed to acquire a stake in the French vaccines company.

Responses